Harbinger Health, Inc. Patent Application Trends in 2024

Harbinger Health, Inc. patent applications in 2024

Top 10 Technology Areas

• C12Q1/6806 (Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay ()
  • Count: 4 patents
  • Example: 20240200122. BODILY FLUID TARGET ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12Q1/6886 (for cancer (immunoassay for cancer)
  • Count: 3 patents
  • Example: 20240200122. BODILY FLUID TARGET ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 3 patents
  • Example: 20240209348. SOLID PHASE NEGATIVE ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12Q1/6827 (for detection of mutation or polymorphism)
  • Count: 2 patents
  • Example: 20240200122. BODILY FLUID TARGET ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12Q1/6848 (characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction)
  • Count: 2 patents
  • Example: 20240209427. RARE NUCLEIC ACID DETECTION simplified abstract (Harbinger Health, Inc.)
• C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 2 patents
  • Example: 20240209427. RARE NUCLEIC ACID DETECTION simplified abstract (Harbinger Health, Inc.)
• C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,)
  • Count: 2 patents
  • Example: 20240209427. RARE NUCLEIC ACID DETECTION simplified abstract (Harbinger Health, Inc.)
• C12N2800/80 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 2 patents
  • Example: 20240209427. RARE NUCLEIC ACID DETECTION simplified abstract (Harbinger Health, Inc.)
• C12Q1/6816 (characterised by the detection means ()
  • Count: 1 patents
  • Example: 20240200122. BODILY FLUID TARGET ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12Q2537/159 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
  • Count: 1 patents
  • Example: 20240200122. BODILY FLUID TARGET ENRICHMENT simplified abstract (Harbinger Health, Inc.)

Emerging Technology Areas

• C12Q2600/106 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
  • Count: 1 patents
  • Example: 20240209427. RARE NUCLEIC ACID DETECTION simplified abstract (Harbinger Health, Inc.)
• G01N2030/8827 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms)
  • Count: 1 patents
  • Example: 20240209348. SOLID PHASE NEGATIVE ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
  • Count: 1 patents
  • Example: 20240209348. SOLID PHASE NEGATIVE ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• G01N27/44756 (using electrophoresis)
  • Count: 1 patents
  • Example: 20240209348. SOLID PHASE NEGATIVE ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12N15/1003 ({Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor})
  • Count: 1 patents
  • Example: 20240209348. SOLID PHASE NEGATIVE ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12N15/1013 ({by using magnetic beads})
  • Count: 1 patents
  • Example: 20240209348. SOLID PHASE NEGATIVE ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12Q2563/149 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
  • Count: 1 patents
  • Example: 20240200122. BODILY FLUID TARGET ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12Q2563/143 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
  • Count: 1 patents
  • Example: 20240200122. BODILY FLUID TARGET ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12Q2537/159 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
  • Count: 1 patents
  • Example: 20240200122. BODILY FLUID TARGET ENRICHMENT simplified abstract (Harbinger Health, Inc.)
• C12Q1/6816 (characterised by the detection means ()
  • Count: 1 patents
  • Example: 20240200122. BODILY FLUID TARGET ENRICHMENT simplified abstract (Harbinger Health, Inc.)

Top Inventors

• Anthony P. Shuber of Northbridge MA (US) (5 patents)
• Jennifer L. Steele of Burlington MA (US) (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors